OS by prior treatment status and treatment arm
| . | Relapsed/refractory patients (N = 177) . | Previously untreated patients (N = 49) . | ||||||
|---|---|---|---|---|---|---|---|---|
| OS at 2 y (%) . | 95% CI . | RR . | 95% CI . | OS at 2 y (%) . | 95% CI . | RR . | 95% CI . | |
| Control | 14 | 6 -21 | 1.00 | — | 5 | 0 -23 | 1.00 | — |
| CsA | 21 | 12 -29 | 0.84 | 0.61 -1.16 | 26 | 9 -43 | 0.41 | 0.22 -0.76 |
| . | Relapsed/refractory patients (N = 177) . | Previously untreated patients (N = 49) . | ||||||
|---|---|---|---|---|---|---|---|---|
| OS at 2 y (%) . | 95% CI . | RR . | 95% CI . | OS at 2 y (%) . | 95% CI . | RR . | 95% CI . | |
| Control | 14 | 6 -21 | 1.00 | — | 5 | 0 -23 | 1.00 | — |
| CsA | 21 | 12 -29 | 0.84 | 0.61 -1.16 | 26 | 9 -43 | 0.41 | 0.22 -0.76 |